For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The Europe Cannabis Testing market is predicted to grow at a CAGR of 10.45% for the forecast period of 2017 - 2025, generating a net worth of $164 million.
The market segments includes by testing methods ( eg: potency cannabis testing, terpene profiling cannabis testing, residual solvent screening cannabis testing, heavy metal cannabis testing, genetic cannabis testing, and microbial analysis cannabis testing), by end-users ( laboratories, research industries), by product and software segments and by Cannabis type( topical, Solid edible, liquid edible and inhaling cannabis). Although the market looks promising, a lack of uniform industry standards and high costs related to laboratory analytical instruments used for cannabis testing are presenting major challenges to the market.
Some of the prominent market players include Agilent Technologies Inc, Sigma-Aldrich, Digipath Inc, Millipore Sigma, Perkinelmer Inc, Steep Hill Halent Laboratories Inc, Pharmlabs Llc, CMT Laboratories Inc, Eli Lilly, Waters Corporation, Thermo Fisher Scientific Inc, Lablynx Inc, and AB SCIEX LLC.